Table 1.
Characteristics | Without 24-h Urine Testing (N=113,186; 87%) | With 24-h Urine Testing (N=17,303; 13%) |
---|---|---|
Age (mean±SD, yr) | 61±14 | 58±12 |
Sex (N, %) | ||
Male | 107,383 (95%) | 16,042 (93%) |
Female | 5803 (5%) | 1261 (7%) |
Race (N, %) | ||
White | 87,541 (77%) | 13,803 (80%) |
Black | 12,540 (11%) | 1521 (9%) |
Other or unknown | 13,105 (12%) | 1979 (11%) |
Laboratory data | ||
BMI (mean±SD, kg/m2) | 29.9±6.2 | 30.7±6.3 |
eGFR (mean±SD, ml/min per 1.73m2) | 73±25 | 77±23 |
Creatinine (mean±SD, mg/dl) | 1.3±2.7 | 1.7±1.4 |
Potassium (mean±SD, mEq/L) | 4.2±0.5 | 4.2±1.1 |
Sodium (mean±SD, mEq/L) | 139±4 | 139±6 |
Bicarbonate (mean±SD, mEq/L) | 27±4 | 27±3 |
Calcium (mean±SD, mg/dl) | 9.3±1.4 | 10.2±1.6 |
Albumin (mean±SD, g/dl) | 4.1±15.1 | 4.1±1.2 |
Comorbidities (N, %) | ||
Hypertension | 76,811 (68%) | 10,944 (63%) |
Gout | 6467 (6%) | 1005 (6%) |
Osteoporosis | 2530 (2%) | 484 (3%) |
Osteopenia | 2259 (2%) | 441 (3%) |
Diabetes mellitus | 42,214 (37%) | 6690 (39%) |
CKD | 3769 (3%) | 430 (2%) |
Cardiovascular disease | 9608 (8%) | 947 (5%) |
Baseline medications (N, %) | ||
Thiazide or thiazide-like diuretics | 19,188 (17%) | 2815 (16%) |
Alkali therapy | 1000 (1%) | 192 (1%) |
Allopurinol | 5861 (5%) | 890 (5%) |
Geographic region (N, %) | ||
Midwest | 27,962 (25%) | 4795 (28%) |
Northeast | 18,737 (17%) | 2244 (13%) |
Southeast | 43,521 (38%) | 5314 (31%) |
West | 22,966 (20%) | 4950 (28%) |
BMI, body mass index.